2019 国际专家共识建议:骨折相关感染一般治疗原则

2019-10-29 国外骨科相关专家小组(统称) Arch Orthop Trauma Surg. 2019 Oct 29.

骨折相关感染(FRI)对于骨科创伤患者及其家庭、临床医生来说仍是一个具有挑战性的并发症。FRI共识组针对骨折相关感染的标准治疗路径提出指导建议,内容涉及一般治疗原则,手术治疗,抗生素治疗,康复和随访。

中文标题:

2019 国际专家共识建议:骨折相关感染一般治疗原则

英文标题:

General treatment principles for fracture-related infection: recommendations from an international expert group.

发布日期:

2019-10-29

简要介绍:

骨折相关感染(FRI)对于骨科创伤患者及其家庭、临床医生来说仍是一个具有挑战性的并发症。FRI共识组针对骨折相关感染的标准治疗路径提出指导建议,内容涉及一般治疗原则,手术治疗,抗生素治疗,康复和随访。

 

拓展指南:骨折相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 国际专家共识建议:骨折相关感染一般治疗原则)] GetToolGuiderByIdResponse(projectId=1, id=3856d1c00182a50e, title=2019 国际专家共识建议:骨折相关感染一般治疗原则, enTitle=General treatment principles for fracture-related infection: recommendations from an international expert group., guiderFrom=Arch Orthop Trauma Surg. 2019 Oct 29., authorId=null, author=, summary=骨折相关感染(FRI)对于骨科创伤患者及其家庭、临床医生来说仍是一个具有挑战性的并发症。FRI共识组针对骨折相关感染的标准治疗路径提出指导建议,内容涉及一般治疗原则,手术治疗,抗生素治疗,康复和随访。 , cover=, journalId=null, articlesId=null, associationId=1089, associationName=国外骨科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Tue Oct 29 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>骨折相关感染(FRI)对于骨科创伤患者及其家庭、临床医生来说仍是一个具有挑战性的并发症。FRI共识组针对骨折相关感染的标准治疗路径提出指导建议,内容涉及一般治疗原则,手术治疗,抗生素治疗,康复和随访。 </P> <P> </P>拓展指南:<strong>与<font color=red>骨折</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=b4d341c001810664" title="中国骨质疏松性骨折骨修复策略专家共识(2019)" target=_blank>中国骨质疏松性骨折骨修复策略专家共识(2019)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=9de531c001e955b1" title="2019 临床共识建议:二次骨折的预防" target=_blank>2019 临床共识建议:二次骨折的预防</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=20a361c001e878ff" title="中国专家共识:骨折固定术后感染诊断与治疗(英文版)" target=_blank>中国专家共识:骨折固定术后感染诊断与治疗(英文版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=923181c001e53a0f" title="中国专家共识:糖尿病患者骨折风险管理(英文版)" target=_blank>中国专家共识:糖尿病患者骨折风险管理(英文版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0bb411c001e52146" title="2019 ACR适宜性标准:肋骨骨折" target=_blank>2019 ACR适宜性标准:肋骨骨折</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E9%AA%A8%E6%8A%98" target=_blank>有关骨折更多指南</a></ul>, tagList=[TagDto(tagId=75879, tagName=骨折相关感染), TagDto(tagId=96579, tagName=一般治疗原则)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7918, appHits=262, showAppHits=0, pcHits=6024, showPcHits=3090, likes=160, shares=11, comments=3, approvalStatus=1, publishedTime=Sat Nov 09 23:02:31 CST 2019, publishedTimeString=2019-10-29, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Nov 09 23:02:31 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 02:33:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 国际专家共识建议:骨折相关感染一般治疗原则)])
2019 国际专家共识建议:骨折相关感染一般治疗原则
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220771, encodeId=0e951220e71d6, content=连指南/共识都要积分,我也是醉了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95cd1393080, createdName=dcyh2009, createdTime=Wed May 18 21:44:43 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214706, encodeId=8e751214e06f1, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:36:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809254, encodeId=a076809254db, content=难题与重点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELupnMTP32hcYJYX9HibnZRssKDY18cvfpKcthFCoaQFiaNJTkyuIDnGLpdSSyoTvfZjibgg1ibqPQuuQ/132, createdBy=911c2026619, createdName=1e22579cm59(暂无匿称), createdTime=Sat Aug 15 21:59:53 CST 2020, time=2020-08-15, status=1, ipAttribution=)]
    2022-05-18 dcyh2009

    连指南/共识都要积分,我也是醉了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1220771, encodeId=0e951220e71d6, content=连指南/共识都要积分,我也是醉了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95cd1393080, createdName=dcyh2009, createdTime=Wed May 18 21:44:43 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214706, encodeId=8e751214e06f1, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:36:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809254, encodeId=a076809254db, content=难题与重点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELupnMTP32hcYJYX9HibnZRssKDY18cvfpKcthFCoaQFiaNJTkyuIDnGLpdSSyoTvfZjibgg1ibqPQuuQ/132, createdBy=911c2026619, createdName=1e22579cm59(暂无匿称), createdTime=Sat Aug 15 21:59:53 CST 2020, time=2020-08-15, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    ***

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1220771, encodeId=0e951220e71d6, content=连指南/共识都要积分,我也是醉了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95cd1393080, createdName=dcyh2009, createdTime=Wed May 18 21:44:43 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214706, encodeId=8e751214e06f1, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:36:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809254, encodeId=a076809254db, content=难题与重点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELupnMTP32hcYJYX9HibnZRssKDY18cvfpKcthFCoaQFiaNJTkyuIDnGLpdSSyoTvfZjibgg1ibqPQuuQ/132, createdBy=911c2026619, createdName=1e22579cm59(暂无匿称), createdTime=Sat Aug 15 21:59:53 CST 2020, time=2020-08-15, status=1, ipAttribution=)]
    2020-08-15 1e22579cm59(暂无匿称)

    难题与重点

    0